Shoulder arthroplasty outcomes in patients with major depressive disorder or generalized anxiety disorder

Q4 Medicine
Noah A. Kuhlmann MS, BS , Sreten Franovic MS, BS , Gabriel B. Burdick BS , Danielle S. Hanson BS , Miriam E. Dash BS , Ayooluwa S. Ayoola MD , Stephanie J. Muh MD
{"title":"Shoulder arthroplasty outcomes in patients with major depressive disorder or generalized anxiety disorder","authors":"Noah A. Kuhlmann MS, BS ,&nbsp;Sreten Franovic MS, BS ,&nbsp;Gabriel B. Burdick BS ,&nbsp;Danielle S. Hanson BS ,&nbsp;Miriam E. Dash BS ,&nbsp;Ayooluwa S. Ayoola MD ,&nbsp;Stephanie J. Muh MD","doi":"10.1053/j.sart.2023.07.005","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Anxiety and depression are among the most common mental health disorders<span> in the United States and have been linked to increased health-care utilization and poorer clinical outcomes. However, data on the relationship between anxiety and depression and outcomes after shoulder arthroplasty (SA) are both limited and conflicting.</span></p></div><div><h3>Methods</h3><p><span><span>This retrospective cohort study<span> examined the influence of a preoperative diagnosis of anxiety and/or major depressive disorder (MDD) on outcomes following shoulder arthroplasty, such as range of motion, pain, perioperative and </span></span>postoperative complications<span>, and readmission rates. A retrospective chart review of our health system’s electronic medical record was performed for dates of service January 2014–December 2019. Patients who underwent primary </span></span>total shoulder arthroplasty<span> or reverse total shoulder arthroplasty<span> were considered for inclusion. These patients were then divided into two groups based on the presence or absence of an anxiety disorder and/or MDD in their past medical history.</span></span></p></div><div><h3>Results</h3><p>595 patients with a minimum follow-up of one year were considered for analysis. Of these, 205 patients (34.5%) had diagnoses of an anxiety and/or MDD and were assigned to the psychiatric comorbidity group, while 390 (65.5%) were assigned to the control group. The psychiatric comorbidity group was significantly younger (68.3 ± 9.3 vs. 70.5 ± 10.0, <em>P</em> = .008) and more heavily female (68.7% vs. 48.7%, <em>P</em> &lt; .001). The length of stay was significantly longer in the psychiatric comorbidity group than in the control group (1.9 ± 2.4 vs. 1.5 ± 0.9 days, <em>P</em><span> = .023). Postoperative range of motion, visual analog scale pain scores (1.8 ± 2.7 vs. 1.3 ± 2.3, </span><em>P</em> = .059), complication rates (7.8% vs. 6.9%, <em>P</em> = .681), and revision rates (4.9% vs. 3.6%, <em>P</em><span> = .448) were not significantly different between the psychiatric comorbidity and control groups, respectively. All-cause emergency department visitation and hospital readmission rates were also similar between the two groups at 30, 60, and 90 days postoperatively.</span></p></div><div><h3>Conclusion</h3><p>Our results suggest that a preoperative diagnosis of MDD or anxiety does not affect pain, postoperative outcomes, complications, or readmission rates following shoulder arthroplasty.</p></div>","PeriodicalId":39885,"journal":{"name":"Seminars in Arthroplasty","volume":"33 4","pages":"Pages 722-726"},"PeriodicalIF":0.0000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seminars in Arthroplasty","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1045452723001153","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Anxiety and depression are among the most common mental health disorders in the United States and have been linked to increased health-care utilization and poorer clinical outcomes. However, data on the relationship between anxiety and depression and outcomes after shoulder arthroplasty (SA) are both limited and conflicting.

Methods

This retrospective cohort study examined the influence of a preoperative diagnosis of anxiety and/or major depressive disorder (MDD) on outcomes following shoulder arthroplasty, such as range of motion, pain, perioperative and postoperative complications, and readmission rates. A retrospective chart review of our health system’s electronic medical record was performed for dates of service January 2014–December 2019. Patients who underwent primary total shoulder arthroplasty or reverse total shoulder arthroplasty were considered for inclusion. These patients were then divided into two groups based on the presence or absence of an anxiety disorder and/or MDD in their past medical history.

Results

595 patients with a minimum follow-up of one year were considered for analysis. Of these, 205 patients (34.5%) had diagnoses of an anxiety and/or MDD and were assigned to the psychiatric comorbidity group, while 390 (65.5%) were assigned to the control group. The psychiatric comorbidity group was significantly younger (68.3 ± 9.3 vs. 70.5 ± 10.0, P = .008) and more heavily female (68.7% vs. 48.7%, P < .001). The length of stay was significantly longer in the psychiatric comorbidity group than in the control group (1.9 ± 2.4 vs. 1.5 ± 0.9 days, P = .023). Postoperative range of motion, visual analog scale pain scores (1.8 ± 2.7 vs. 1.3 ± 2.3, P = .059), complication rates (7.8% vs. 6.9%, P = .681), and revision rates (4.9% vs. 3.6%, P = .448) were not significantly different between the psychiatric comorbidity and control groups, respectively. All-cause emergency department visitation and hospital readmission rates were also similar between the two groups at 30, 60, and 90 days postoperatively.

Conclusion

Our results suggest that a preoperative diagnosis of MDD or anxiety does not affect pain, postoperative outcomes, complications, or readmission rates following shoulder arthroplasty.

重度抑郁症或广泛性焦虑症患者肩关节置换术的疗效
背景:焦虑和抑郁是美国最常见的精神健康障碍,与医疗保健使用率增加和临床结果较差有关。然而,关于肩关节置换术(SA)后焦虑和抑郁与预后之间关系的数据既有限又相互矛盾。方法:本回顾性队列研究探讨了术前焦虑和/或重度抑郁症(MDD)诊断对肩关节置换术后结果的影响,如活动范围、疼痛、围手术期和术后并发症以及再入院率。对2014年1月至2019年12月服务日期的卫生系统电子病历进行了回顾性图表审查。接受初次全肩关节置换术或反向全肩关节置换术的患者被纳入研究范围。然后根据患者过去病史中是否存在焦虑症和/或重度抑郁症将这些患者分为两组。结果595例最低随访1年的患者纳入分析。其中,205名患者(34.5%)被诊断为焦虑和/或重度抑郁症,并被分配到精神共病组,而390名患者(65.5%)被分配到对照组。精神疾病合并症组明显年轻化(68.3±9.3比70.5±10.0,P = 0.008),女性患病率更高(68.7%比48.7%,P <措施)。精神共病组住院时间明显长于对照组(1.9±2.4天vs. 1.5±0.9天,P = 0.023)。术后活动范围、视觉模拟量表疼痛评分(1.8±2.7比1.3±2.3,P = 0.059)、并发症发生率(7.8%比6.9%,P = 0.681)和翻修率(4.9%比3.6%,P = 0.448)在精神合并症组和对照组之间分别无显著差异。两组在术后30、60和90天的全因急诊就诊率和再入院率也相似。结论:我们的研究结果表明,术前诊断MDD或焦虑不会影响肩关节置换术后的疼痛、术后结果、并发症或再入院率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Seminars in Arthroplasty
Seminars in Arthroplasty Medicine-Surgery
CiteScore
1.00
自引率
0.00%
发文量
104
期刊介绍: Each issue of Seminars in Arthroplasty provides a comprehensive, current overview of a single topic in arthroplasty. The journal addresses orthopedic surgeons, providing authoritative reviews with emphasis on new developments relevant to their practice.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信